195 results on '"Tokunaga, Masahito"'
Search Results
2. Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study
3. Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
4. Intragenic silencer regulates human retrovirus latency by recruiting RUNX1
5. Long-term follow-up of patients with ATL after autologous stem cell transplantation
6. Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
7. Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
8. HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma
9. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia
10. Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
11. Detection of an early adult T-cell leukemia-lymphoma clone in lymph nodes with anaplastic lymphoma kinase-negative anaplastic large cell lymphoma involvement
12. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
13. A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan
14. Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma
15. Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105
16. Recovery of physical function, muscle mass and quality of life in patients undergoing allogeneic hematopoietic stem cell transplantation
17. CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
18. Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
19. Improved outcome of adult T-cell leukemia-lymphoma with cord blood transplantation: a nationwide retrospective study
20. Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation
21. Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection
22. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma
23. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia–lymphoma: Comparison between cutaneous type and other subtypes
24. M-Sec induced by HTLV-1 mediates an efficient viral transmission
25. P-126: The prognostic impact of the UK Myeloma Research Alliance Risk Profile in untreated patients with multiple myeloma who received melphalan, prednisolone, and bortezomib: an ad hoc analysis of JCOG1105
26. Retrovirus-induced leukemia – hijack of T-cell activation mechanisms revealed by single-cell analysis
27. Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma
28. Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia–lymphoma: Cutaneous adverse reactions may predict the prognosis
29. Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
30. Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
31. Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
32. Adult T-Cell Leukemia in a Liver Transplant Recipient That Did Not Progress after Onset of Graft Rejection
33. Discovery and Characterization of a Hidden Retroviral Enhancer by Viral DNA-capture-seq Approach
34. Adult T-cell leukemia/lymphoma in a 21-year-old man
35. CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
36. Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm
37. The Presence and Possible Role of Virus-Host Chimeric Transcripts in Adult T-Cell Leukemia-Lymphoma
38. Cord Blood Transplantation with Non-TBI-RIC Regimen Using Fludarabine and Melphalan for Adult T-Cell Leukemia / Lymphoma
39. The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach
40. Prognostic impact of soluble interleukin‐2 receptor level profiling in smoldering type adult T‐cell leukemia‐lymphoma
41. The Nature of HTLV-1 Provirus in Naturally Infected Individuals Analyzed by Viral DNA-Capture-Seq Approach
42. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma
43. Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma
44. Newly identified poor prognostic factors for adult T-cell leukemia–lymphoma treated with allogeneic hematopoietic stem cell transplantation
45. Mogamulizumab Therapy for Adult T-Cell Leukemia-Lymphoma: A Retrospective Multicenter Study
46. Umbilical Cord Blood Transplantation with Non-TBI Regimens for Advanced Hematological Malignant Diseases
47. Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
48. A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.
49. Highly Sensitive Viral RNA-Seq Is a Powerful Tool to Analyze the Viral Transcripts in HTLV-1-Infected Individuals
50. Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.